1-3 of 3
Joel N. Hirschhorn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CYP19A1 Genetic Variation in Relation to Prostate Cancer Risk and Circulating Sex Hormone Concentrations in Men from the Breast and Prostate Cancer Cohort Consortium

Free
Ruth C. Travis, Fredrick Schumacher, Joel N. Hirschhorn, Peter Kraft, Naomi E. Allen, Demetrius Albanes, Goran Berglund, Sonja I. Berndt, Heiner Boeing, H. Bas Bueno-de-Mesquita, Eugenia E. Calle, Stephen Chanock, Alison M. Dunning, Richard Hayes, Heather Spencer Feigelson, J. Michael Gaziano, Edward Giovannucci, Christopher A. Haiman, Brian E. Henderson, Rudolf Kaaks, Laurence N. Kolonel, Jing Ma, Laudina Rodriguez, Elio Riboli, Meir Stampfer, Daniel O. Stram, Michael J. Thun, Anne Tjønneland, Dimitrios Trichopoulos, Paolo Vineis, Jarmo Virtamo, Loïc Le Marchand, David J. Hunter
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2009) 18 (10): 2734–2744.
https://doi.org/10.1158/1055-9965.EPI-09-0496
Published: 08 October 2009
View articletitled, CYP19A1 Genetic Variation in Relation to Prostate Cancer Risk and Circulating Sex Hormone Concentrations in Men from the Breast and Prostate Cancer Cohort Consortium
Open the PDF for CYP19A1 Genetic Variation in Relation to Prostate Cancer Risk and Circulating Sex Hormone Concentrations in Men from the Breast and Prostate Cancer Cohort Consortium in another window
Includes: Supplementary data
Journal Articles

Comprehensive Evaluation of ESR2 Variation and Ovarian Cancer Risk

Free
Celeste Leigh Pearce, Aimee M. Near, Johannah L. Butler, David Van Den Berg, Philip Bretsky, David V. Conti, Daniel O. Stram, Malcolm C. Pike, Joel N. Hirschhorn, Anna H. Wu
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2008) 17 (2): 393–396.
https://doi.org/10.1158/1055-9965.EPI-07-2512
Published: 11 February 2008
View articletitled, Comprehensive Evaluation of ESR2 Variation and Ovarian Cancer Risk
Open the PDF for Comprehensive Evaluation of ESR2 Variation and Ovarian Cancer Risk in another window
Journal Articles

CYP17 Genetic Variation and Risk of Breast and Prostate Cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

Free
Veronica Wendy Setiawan, Fredrick R. Schumacher, Christopher A. Haiman, Daniel O. Stram, Demetrius Albanes, David Altshuler, Göran Berglund, Julie Buring, Eugenia E. Calle, Françoise Clavel-Chapelon, David G. Cox, J. Michael Gaziano, Susan E. Hankinson, Richard B. Hayes, Brian E. Henderson, Joel N. Hirschhorn, Robert Hoover, David J. Hunter, Rudolf Kaaks, Laurence N. Kolonel, Peter Kraft, Jing Ma, Loïc Le Marchand, Jakob Linseisen, Eiliv Lund, Carmen Navarro, Kim Overvad, Domenico Palli, Petra H.M. Peeters, Malcolm C. Pike, Elio Riboli, Meir J. Stampfer, Michael J. Thun, Ruth C. Travis, Dimitrios Trichopoulos, Meredith Yeager, Regina G. Ziegler, Heather Spencer Feigelson, Stephen J. Chanock
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2007) 16 (11): 2237–2246.
https://doi.org/10.1158/1055-9965.EPI-07-0589
Published: 15 November 2007
View articletitled, CYP17 Genetic Variation and Risk of Breast and Prostate Cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
Open the PDF for CYP17 Genetic Variation and Risk of Breast and Prostate Cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) in another window
Includes: Supplementary data